comparemela.com

NEW YORK CITY (dpa-AFX) - IDEAYA Biosciences, Inc. (IDYA) has amended its clinical trial collaboration and supply agreements with Pfizer Inc. (PFE) to support evaluation of darovasertib and crizotinib

Related Keywords

Gewinn Nur , Biosciences Inc , Pfizer Inc , More Such Health News , Pfizer , Pfizer Agreement , Ideaya , Nnounces , Amended , Linical , Trial , Collaboration , Supply , Agreements , Ith ,

© 2024 Vimarsana

comparemela.com © 2020. All Rights Reserved.